Literature DB >> 1330945

Differing effects of delta-9-tetrahydrocannabinol (THC) on murine spleen cell populations dependent upon stimulators.

S H Pross1, Y Nakano, R Widen, S McHugh, C A Newton, T W Klein, H Friedman.   

Abstract

Delta-9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana, can suppress the immune response, both in vitro and in vivo. In the present study, THC was found to either up-regulate or down-regulate lymphocytes depending on the method of stimulation. When the mitogens concanavalin A (Con A) or phytohemagglutinin (PHA) were used to stimulate THC-treated splenocytes, a down-regulation of lymphocyte proliferation occurred, which reflected lower T-cell numbers in general and Ly2 positive cells specifically. When splenocytes were stimulated directly by using anti-CD3 antibody it was found that low concentrations of THC enhanced lymphocyte proliferation, T-cell numbers in general, and Ly2 cells specifically. These results emphasize that THC can either enhance or suppress aspects of the immune response, depending on the specific immune stimulants used and the specific parameter of immunity measured.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330945     DOI: 10.1016/0192-0561(92)90146-c

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  5 in total

Review 1.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

2.  Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120.

Authors:  Weimin Chen; Barbara L F Kaplan; Schuyler T Pike; Lauren A Topper; Nicholas R Lichorobiec; Steven O Simmons; Ram Ramabhadran; Norbert E Kaminski
Journal:  J Leukoc Biol       Date:  2012-08-16       Impact factor: 4.962

3.  Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation.

Authors:  Saphala Dhital; John V Stokes; Nogi Park; Keun Seok Seo; Barbara L F Kaplan
Journal:  Cell Immunol       Date:  2016-11-09       Impact factor: 4.868

4.  Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice.

Authors:  Peer W F Karmaus; James G Wagner; Jack R Harkema; Norbert E Kaminski; Barbara L F Kaplan
Journal:  J Immunotoxicol       Date:  2012-11-23       Impact factor: 3.000

Review 5.  The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism.

Authors:  Marcel Jenny; Sebastian Schröcksnadel; Florian Überall; Dietmar Fuchs
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.